Click to listen to the introduction to my interview about molecular diagnostics reimbursement with Joe Anderson on his Personalized Diagnostics Podcast! http://thepdxpodcast.cast.rocks/
“How exactly are molecular diagnostics tests reimbursed? Is our coding and reimbursement system up to the task? Roger D. Klein MD, JD, FCAP is a former HHS Advisor to FDA, CMS and CDC, and the immediate past chair of the Association for Molecular Pathology (AMP) Solid Tumors Division. A physician and an attorney, Dr Klein served as an expert and key spokesperson in the lawsuit “Association for Molecular Pathology v. Myriad Genetics, Inc.” in which the U.S. Supreme Court invalidated patents on breast cancer genes. He is a leading authority on public policies related to the implementation of precision medicine.” https://www.linkedin.com/posts/joseph-anderson-md-b447b3_how-exactly-are-molecular-diagnostics-tests-activity-6612762934676455424-QkSM